← P3 Health Partners Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| TOTAL OPERATING REVENUE | $145.5m |
$491.1m
+237.54%
|
$578.6m
+17.83%
|
$1.0b
+81.38%
|
$1.3b
+20.67%
|
$1.5b
+18.48%
|
$1.5b
-2.76%
|
$1.5b
+0.90%
|
|
| Sales and marketing expense | $802k | $1.5m | $1.8m | $5.1m | $3.2m | $1.3m | $918k | — | |
| Corporate, general and administrative expense | $36.4m | $53.4m | $100.2m | $157.3m | $122.4m | $112.6m | $106.3m | — | |
| OPERATING LOSS | ($39.5m) |
($28.6m)
+27.69%
|
($129.1m)
-351.44%
|
($1.6b)
-1109.47%
|
($167.9m)
+89.24%
|
($320.7m)
-90.95%
|
($270.3m)
+15.70%
|
($224.0m)
+17.14%
|
|
| Interest expense, net | ($2.5m) | ($2.5m) | ($9.7m) | ($11.4m) | ($16.0m) | ($22.2m) | ($55.0m) | $63.1m | |
| Gain (Loss) on Disposition of Assets | — | — | — | — | $0 | $13.3m | ($162k) | — | |
| TOTAL OTHER INCOME (EXPENSE) | ($2.4m) | ($2.8m) | ($17.3m) | $1.2m | ($15.8m) | $14.7m | ($50.8m) | ||
| LOSS BEFORE INCOME TAXES | ($42.0m) | ($31.4m) | ($146.4m) | ($1.6b) | ($183.7m) | ($306.0m) | ($321.1m) | ||
| INCOME TAX PROVISION | $0 | $0 | $0 | ($1.9m) | ($2.7m) | ($4.4m) | ($2.0m) | ||
| NET LOSS | ($42.0m) | ($31.4m) | ($146.4m) | ($1.6b) | ($186.4m) | ($310.4m) | ($323.1m) | ||
| LESS: NET LOSS ATTRIBUTABLE TO REDEEMABLE NON-CONTROLLING INTEREST | $0 | $0 | ($1.3b) | ($128.7m) | ($174.5m) | ($175.1m) | |||
| NET LOSS ATTRIBUTABLE TO CONTROLLING INTEREST | ($42.0m) | ($31.4m) | ($146.4m) | ($270.1m) | ($57.8m) | ($135.8m) | ($147.9m) | ||
| Basic (in dollars per share) | — | — | — | ($6.50) | ($1.96) | ($2.14) | ($98.83) | — | |
| Diluted (in dollars per share) | — | — | — | ($6.50) | ($0.63) | ($2.11) | ($98.83) | — | |
| Medical expense | $141.0m | $484.5m | $592.5m | $1.1b | $1.2b | $1.6b | $1.5b | — | |
| Premium deficiency reserve | $6.4m | ($20.5m) | $11.6m | ($11.5m) | ($12.7m) | $53.7m | $18.7m | — | |
| Depreciation and amortization | $399k | $795k | $1.5m | $87.3m | $86.7m | $86.1m | $84.2m | $84.2m | |
| Impairment of assets held for sale | — | — | — | — | $0 | $8.1m | $0 | — | |
| Mark-to-market of stock warrants | — | — | ($7.7m) | $9.9m | $433k | $22.1m | $7.8m | — | |
| Other | $98k | ($291k) | $147k | $2.8m | ($249k) | $1.5m | ($3.4m) | — | |
| TOTAL OPERATING EXPENSE | $185.0m | $519.7m | $707.7m | $2.6b | $1.4b | $1.8b | $1.7b | $1.7b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.